1. 1) Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM. 11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr. Rev., 25, 831–866 (2004).
2. 2) Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet, 367, 1605–1617 (2006).
3. 3) Wang M. Tissue-specific glucocorticoid excess in the metabolic syndrome: 11β-HSD1 as a therapeutic target. Drug Dev. Res., 67, 567–569 (2006).
4. 4) Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. A transgenic model of visceral obesity and the metabolic syndrome. Science, 294, 2166–2170 (2001).
5. 5) Jump DB, Botolin D, Wang Y, Xu J, Christian B, Demeure O. Fatty acid regulation of hepatic gene transcription. J. Nutr., 135, 2503–2506 (2005).